Abstract
L-Asparaginase is a bacterial enzyme used in the treatment of acute lymphoblastic leukemia. In the ongoing U.S. Drug-Induced Liver Injury Network (DILIN) prospective study, standard and pegylated asparaginase were the most frequent cause of liver injury with jaundice among anti-cancer agents (8 of 40: 20%). The unique features of this hepatotoxicity are described. Eight cases from 5 DILIN centers were reviewed for clinical course, laboratory values, imaging, and histopathology. Seven females, aged 29-59 years, and one 8-year-old boy, all with leukemia, developed jaundice within 9-21 days (median 15 days) of starting asparaginase or pegaspargase, during the first (n = 6) or second (n = 2) cycle. Prominent symptoms were jaundice (n = 8), fatigue (6), abdominal pain (6) but rarely pruritus (1). Initial median ALT level was 284 U/L (range 83-1076), Alk P 159 U/L (64-452), and bilirubin 4.4 mg/dL (3.7-8.4). Bilirubin levels rose thereafter in all patients to median peak of 17.5 mg/dL (11.7-25.7), INR rose to 1.1-1.7 and serum albumin fell to 1.5-2.6 g/dL. Hepatic imaging revealed fatty liver in all patients. Liver biopsy showed steatosis but minimal hepatocyte necrosis. One patient restarted on pegaspargase re-developed less severe ...Continue Reading
References
Jun 1, 1968·The Journal of Experimental Medicine·J D Broome
Feb 1, 1970·Cancer·H F OettgenJ H Burchenal
Aug 1, 1971·Cancer·C B Pratt, W W Johnson
May 3, 1968·Science·B HorowitzE Stockert
Feb 27, 2001·Blood·L B SilvermanS E Sallan
Oct 3, 2003·Seminars in Liver Disease·Sunati Sahoo, John Hart
Sep 22, 2006·Digestion·Michael BodmerStephan Krähenbühl
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert J FontanaUNKNOWN DILIN Study Group
Jun 1, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Don C RockeyUNKNOWN US Drug-Induced Liver Injury Network
Aug 21, 2010·Journal of Pediatric Hematology/oncology·Elizabeth A Raetz, Wanda L Salzer
Aug 11, 2011·Leukemia & Lymphoma·Wendy StockArchie Bleyer
Oct 5, 2013·Leukemia & Lymphoma·Chadi Al-NawakilLaurence Moachon
Nov 7, 2013·Chemotherapy·Anne RoesmannRene H Tolba
Sep 19, 2014·Blood·Loren GragertBrian T Hill
Mar 11, 2015·Gastroenterology·Naga ChalasaniUNKNOWN United States Drug Induced Liver Injury Network
Jun 23, 2015·European Journal of Haematology·Ibrahim AldossVinod Pullarkat
Oct 13, 2015·Leukemia & Lymphoma·Nobuko Hijiya, Inge M van der Sluis
Feb 4, 2016·Acta Haematologica·Ruham Alshiekh-Nasany, Dan Douer
Jul 22, 2016·Journal of Pharmacology & Pharmacotherapeutics·Rachel A EglerYousif Matloub
Oct 27, 2016·Leukemia Research·Troy Z HorvatDan Douer
Feb 17, 2017·PloS One·Jason H KarnesDan M Roden
May 20, 2017·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Alison BlackmanNicholas Forcello
Feb 7, 2018·Leukemia Research·Patrick W BurkeDan Douer
Citations
Dec 13, 2019·Case Reports in Hematology·Guillaume BeziatFrançoise Huguet
Oct 11, 2020·ESMO Open·Patrick W BurkeDan Douer
Nov 27, 2020·PeerJ·Iván González-TorresAlejandro Huerta-Saquero
Dec 2, 2020·Leukemia & Lymphoma·Zachary E WestTamara P Miller
Oct 18, 2020·Alcoholism, Clinical and Experimental Research·Olli KärkkäinenJaana Rysä
May 13, 2021·Current Hematologic Malignancy Reports·David O RileyFiras El Chaer
May 25, 2021·Frontiers in Pharmacology·Pragyan AcharyaRalf Weiskirchen
Sep 7, 2021·Frontiers in Oncology·Di ZengJing Li
Oct 7, 2021·Preparative Biochemistry & Biotechnology·Hesham SaeedNefertiti El-Nikhely